Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Development (Cambridge, England)
|
September 19, 2009
Akt-dependent Pp2a activity is required for epidermal barrier formation during late embryonic development
Ryan F L O'Shaughnessy, Jonathan C Welti, Katherine Sully, et al.
The Journal of Biological Chemistry
|
January 24, 2013
Essential role for endocytosis in the growth factor-stimulated activation of ERK1/2 in endothelial cells
Morgane Gourlaouen, Jonathan C Welti, Naveen S Vasudev, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
November 13, 2009
Whole-mount assays for gene induction and barrier formation in the developing epidermis
Carolyn Byrne, Ariel A Avilion, Ryan F O'Shaughnessy, et al.
The Journal of Biological Chemistry
|
April 19, 2007
AKT-dependent HspB1 (Hsp27) activity in epidermal differentiation
Ryan F L O'Shaughnessy, Jonathan C Welti, James C Cooke, et al.
Nature Reviews. Clinical Oncology
|
August 24, 2018
Alternative splicing in prostate cancer
Alec Paschalis, Adam Sharp, Jonathan C Welti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 3, 2019
Dissecting Prognostic From Predictive Utility: Circulating AR-V7 Biomarker Testing for Advanced Prostate Cancer
Adam Sharp, Nuria Porta, Maryou B K Lambros, et al.
Cancer Research
|
November 29, 2012
Lysyl oxidase plays a critical role in endothelial cell stimulation to drive tumor angiogenesis
Ann-Marie Baker, Demelza Bird, Jonathan C Welti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 30, 2011
FGFR signaling promotes the growth of triple-negative and basal-like breast cancer cell lines both in vitro and in vivo
Rachel Sharpe, Alex Pearson, Maria T Herrera-Abreu, et al.
Molecular Cancer Therapeutics
|
October 22, 2015
Preclinical Evidence That Trametinib Enhances the Response to Antiangiogenic Tyrosine Kinase Inhibitors in Renal Cell Carcinoma
Victoria L Bridgeman, Elaine Wan, Shane Foo, et al.
Angiogenesis
|
July 31, 2012
Contrasting effects of sunitinib within in vivo models of metastasis
Jonathan C Welti, Thomas Powles, Shane Foo, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Development (Cambridge, England)
|
September 19, 2009
Akt-dependent Pp2a activity is required for epidermal barrier formation during late embryonic development
Ryan F L O'Shaughnessy, Jonathan C Welti, Katherine Sully, et al.
The Journal of Biological Chemistry
|
January 24, 2013
Essential role for endocytosis in the growth factor-stimulated activation of ERK1/2 in endothelial cells
Morgane Gourlaouen, Jonathan C Welti, Naveen S Vasudev, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
November 13, 2009
Whole-mount assays for gene induction and barrier formation in the developing epidermis
Carolyn Byrne, Ariel A Avilion, Ryan F O'Shaughnessy, et al.
The Journal of Biological Chemistry
|
April 19, 2007
AKT-dependent HspB1 (Hsp27) activity in epidermal differentiation
Ryan F L O'Shaughnessy, Jonathan C Welti, James C Cooke, et al.
Nature Reviews. Clinical Oncology
|
August 24, 2018
Alternative splicing in prostate cancer
Alec Paschalis, Adam Sharp, Jonathan C Welti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 3, 2019
Dissecting Prognostic From Predictive Utility: Circulating AR-V7 Biomarker Testing for Advanced Prostate Cancer
Adam Sharp, Nuria Porta, Maryou B K Lambros, et al.
Cancer Research
|
November 29, 2012
Lysyl oxidase plays a critical role in endothelial cell stimulation to drive tumor angiogenesis
Ann-Marie Baker, Demelza Bird, Jonathan C Welti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 30, 2011
FGFR signaling promotes the growth of triple-negative and basal-like breast cancer cell lines both in vitro and in vivo
Rachel Sharpe, Alex Pearson, Maria T Herrera-Abreu, et al.
Molecular Cancer Therapeutics
|
October 22, 2015
Preclinical Evidence That Trametinib Enhances the Response to Antiangiogenic Tyrosine Kinase Inhibitors in Renal Cell Carcinoma
Victoria L Bridgeman, Elaine Wan, Shane Foo, et al.
Angiogenesis
|
July 31, 2012
Contrasting effects of sunitinib within in vivo models of metastasis
Jonathan C Welti, Thomas Powles, Shane Foo, et al.
Page
of 2